UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

Annals of oncology, 2011-11, Vol.22 (11), p.2476-2481

2011

Volltextzugriff (PDF)

Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

Journal of clinical oncology, 2002-07, Vol.20 (14), p.3114-3121

2002

Volltextzugriff (PDF)

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Annals of oncology, 2006-01, Vol.17 (1), p.85-92

2006

Volltextzugriff (PDF)

Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure

British journal of cancer, 2002-11, Vol.87 (11), p.1210-1215

2002

Volltextzugriff (PDF)

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer

European journal of cancer (1990), 2004-05, Vol.40 (7), p.1021-1030

2004

Volltextzugriff (PDF)

Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial

Annals of oncology, 2006-08, Vol.17 (8), p.1221-1227

2006

Volltextzugriff (PDF)

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group

Annals of oncology, 2005-08, Vol.16 (8), p.1343-1351

2005

Volltextzugriff (PDF)

Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (6), p.555-562

2008

Volltextzugriff (PDF)

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Critical reviews in oncology/hematology, 2010-10, Vol.76 (1), p.71-78

2010

Volltextzugriff (PDF)

Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: A randomized phase 2 trial

Critical reviews in oncology/hematology, 2007-10, Vol.64 (1), p.64-72

2007

Volltextzugriff (PDF)

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

Annals of oncology, 2006-01, Vol.17 (1), p.65-73

2006

Volltextzugriff (PDF)

Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer : French Adjuvant Study Group 09 trial

British journal of cancer, 2007-06, Vol.96 (11), p.1633-1638

2007

Volltextzugriff (PDF)

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3115-3124

the French Epirubicin Study Group

2000

Volltextzugriff (PDF)

Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor

The American journal of surgical pathology, 1997-09, Vol.21 (9), p.1113-1118

1997

Volltextzugriff (PDF)

Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Year Follow-Up Results of the French Adjuvant Study Group 05 Randomized Trial

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2686-2693

2005

Volltextzugriff (PDF)

A study from the EORTC new drug development group: Open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer

European journal of cancer (1990), 2006, Vol.42 (2), p.200-204

2006

Volltextzugriff (PDF)

Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4179-4191

2005

Volltextzugriff (PDF)

Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy

Annales de biologie clinique (Paris), 2008-09, Vol.66 (5), p.515

2008

Volltextzugriff (PDF)

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1564-1571

1995

Volltextzugriff (PDF)

Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1136-1145

1996

Volltextzugriff (PDF)

Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy

Annales de biologie clinique (Paris), 2008-09, Vol.66 (5), p.523-530

2008

Volltextzugriff (PDF)

Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer : a 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)

Breast cancer research and treatment, 2000-11, Vol.64 (2), p.189-191

2000

Volltextzugriff (PDF)

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer

Cancer chemotherapy and pharmacology, 2004-03, Vol.53 (3), p.233-238

2004

Volltextzugriff (PDF)

Disease-Free Survival Advantage of Weekly Epirubicin Plus Tamoxifen Versus Tamoxifen Alone As Adjuvant Treatment of Operable, Node-Positive, Elderly Breast Cancer Patients: 6-Year Follow-Up Results of the French Adjuvant Study Group 08 Trial

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4674-4630

2004

Volltextzugriff (PDF)

Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer

Cancer chemotherapy and pharmacology, 2003-08, Vol.52 (2), p.99-107

2003

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(93)
Female
(72)
Middle Aged
(72)
Science & Technology
(70)
Life Sciences & Biomedicine
(65)
Aged
(59)
Adult
(56)
Oncology
(54)
Biological And Medical Sciences
(52)
Medical Sciences
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(43)
Breast Neoplasms - Drug Therapy
(39)
Male
(38)
Pharmacology. Drug Treatments
(38)
Antineoplastic Agents
(32)
Chemotherapy
(30)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(26)
Fluorouracil - Administration & Dosage
(21)
Treatment Outcome
(20)
Tumors
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer

Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group

Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: A randomized phase 2 trial

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer : French Adjuvant Study Group 09 trial

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor

Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Year Follow-Up Results of the French Adjuvant Study Group 05 Randomized Trial

A study from the EORTC new drug development group: Open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer

Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide

Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration

Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy

Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer : a 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer

Disease-Free Survival Advantage of Weekly Epirubicin Plus Tamoxifen Versus Tamoxifen Alone As Adjuvant Treatment of Operable, Node-Positive, Elderly Breast Cancer Patients: 6-Year Follow-Up Results of the French Adjuvant Study Group 08 Trial

Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer

Suchergebnisse filtern